Crossmark

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials

Crossref DOI link: https://doi.org/10.1186/s12885-020-06933-y

Published Online: 2020-05-13

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Omarini, Claudia http://orcid.org/0000-0002-2906-7896
Piacentini, Federico

Sperduti, Isabella

Barbolini, Monica

Isca, Chrystel

Toss, Angela

Cortesi, Laura

Barbieri, Elena

Dominici, Massimo

Moscetti, Luca
License Information

Text and Data Mining valid from 2020-05-13

Version of Record valid from 2020-05-13
More Information

Article History

Received: 10 February 2020

Accepted: 5 May 2020

First Online: 13 May 2020

Ethics approval and consent to participate

: This article does not contain any studies with human participants or animals performed by any of the authors.

: N/A

: The authors declare that they have not conflicts of interest.

Document is current

Any future updates will be listed below